nodes	percent_of_prediction	percent_of_DWPC	metapath
Losartan—ABCB1—peripheral nervous system neoplasm	0.255	1	CbGaD
Losartan—UGT2B7—Epirubicin—peripheral nervous system neoplasm	0.0741	0.151	CbGbCtD
Losartan—UGT1A1—Etoposide—peripheral nervous system neoplasm	0.0499	0.102	CbGbCtD
Losartan—CYP3A5—Tretinoin—peripheral nervous system neoplasm	0.0361	0.0737	CbGbCtD
Losartan—CYP2C8—Tretinoin—peripheral nervous system neoplasm	0.0347	0.0708	CbGbCtD
Losartan—CYP1A2—Alitretinoin—peripheral nervous system neoplasm	0.0289	0.059	CbGbCtD
Losartan—ABCB1—Topotecan—peripheral nervous system neoplasm	0.0253	0.0516	CbGbCtD
Losartan—ABCB1—Alitretinoin—peripheral nervous system neoplasm	0.0253	0.0516	CbGbCtD
Losartan—CYP2C9—Tretinoin—peripheral nervous system neoplasm	0.0242	0.0494	CbGbCtD
Losartan—CYP1A2—Dacarbazine—peripheral nervous system neoplasm	0.0231	0.0471	CbGbCtD
Losartan—ABCB1—Dactinomycin—peripheral nervous system neoplasm	0.0175	0.0357	CbGbCtD
Losartan—CYP3A5—Vincristine—peripheral nervous system neoplasm	0.0166	0.0338	CbGbCtD
Losartan—CYP3A5—Etoposide—peripheral nervous system neoplasm	0.0152	0.031	CbGbCtD
Losartan—CYP3A4—Topotecan—peripheral nervous system neoplasm	0.0152	0.0309	CbGbCtD
Losartan—CYP2C8—Etoposide—peripheral nervous system neoplasm	0.0146	0.0298	CbGbCtD
Losartan—CYP3A4—Tretinoin—peripheral nervous system neoplasm	0.0141	0.0287	CbGbCtD
Losartan—CYP1A2—Etoposide—peripheral nervous system neoplasm	0.0113	0.0231	CbGbCtD
Losartan—ABCB1—Vincristine—peripheral nervous system neoplasm	0.0108	0.022	CbGbCtD
Losartan—CYP2C9—Cisplatin—peripheral nervous system neoplasm	0.0104	0.0212	CbGbCtD
Losartan—ABCB1—Cisplatin—peripheral nervous system neoplasm	0.0101	0.0205	CbGbCtD
Losartan—ABCB1—Etoposide—peripheral nervous system neoplasm	0.00989	0.0202	CbGbCtD
Losartan—ABCB1—Doxorubicin—peripheral nervous system neoplasm	0.00675	0.0138	CbGbCtD
Losartan—CYP3A4—Vincristine—peripheral nervous system neoplasm	0.00647	0.0132	CbGbCtD
Losartan—CYP3A4—Etoposide—peripheral nervous system neoplasm	0.00593	0.0121	CbGbCtD
Losartan—CYP3A4—Doxorubicin—peripheral nervous system neoplasm	0.00404	0.00824	CbGbCtD
Losartan—Telmisartan—ABCB1—peripheral nervous system neoplasm	0.000367	0.554	CrCbGaD
Losartan—Candesartan—ABCB1—peripheral nervous system neoplasm	0.000296	0.446	CrCbGaD
Losartan—Tachycardia—Etoposide—peripheral nervous system neoplasm	0.000131	0.000577	CcSEcCtD
Losartan—Eosinophilia—Epirubicin—peripheral nervous system neoplasm	0.000131	0.000577	CcSEcCtD
Losartan—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000131	0.000577	CcSEcCtD
Losartan—Body temperature increased—Vincristine—peripheral nervous system neoplasm	0.000131	0.000577	CcSEcCtD
Losartan—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.00013	0.000575	CcSEcCtD
Losartan—Dry skin—Doxorubicin—peripheral nervous system neoplasm	0.00013	0.000572	CcSEcCtD
Losartan—Hyperhidrosis—Etoposide—peripheral nervous system neoplasm	0.00013	0.000572	CcSEcCtD
Losartan—Pancreatitis—Epirubicin—peripheral nervous system neoplasm	0.00013	0.000571	CcSEcCtD
Losartan—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000129	0.00057	CcSEcCtD
Losartan—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000129	0.000568	CcSEcCtD
Losartan—Breast disorder—Doxorubicin—peripheral nervous system neoplasm	0.000128	0.000564	CcSEcCtD
Losartan—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000128	0.000564	CcSEcCtD
Losartan—Toxic epidermal necrolysis—Doxorubicin—peripheral nervous system neoplasm	0.000127	0.000562	CcSEcCtD
Losartan—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000127	0.000561	CcSEcCtD
Losartan—Bronchitis—Epirubicin—peripheral nervous system neoplasm	0.000127	0.00056	CcSEcCtD
Losartan—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000127	0.000559	CcSEcCtD
Losartan—Hypersensitivity—Alitretinoin—peripheral nervous system neoplasm	0.000127	0.000558	CcSEcCtD
Losartan—Hypotension—Etoposide—peripheral nervous system neoplasm	0.000125	0.000552	CcSEcCtD
Losartan—Gastritis—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.000552	CcSEcCtD
Losartan—Pain—Cisplatin—peripheral nervous system neoplasm	0.000125	0.000552	CcSEcCtD
Losartan—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000125	0.00055	CcSEcCtD
Losartan—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000123	0.000543	CcSEcCtD
Losartan—Upper respiratory tract infection—Epirubicin—peripheral nervous system neoplasm	0.000123	0.000542	CcSEcCtD
Losartan—Influenza—Doxorubicin—peripheral nervous system neoplasm	0.000122	0.000539	CcSEcCtD
Losartan—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000122	0.000538	CcSEcCtD
Losartan—Hypersensitivity—Vincristine—peripheral nervous system neoplasm	0.000122	0.000538	CcSEcCtD
Losartan—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000121	0.000536	CcSEcCtD
Losartan—Eosinophilia—Doxorubicin—peripheral nervous system neoplasm	0.000121	0.000534	CcSEcCtD
Losartan—Photosensitivity reaction—Epirubicin—peripheral nervous system neoplasm	0.000121	0.000532	CcSEcCtD
Losartan—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000121	0.000532	CcSEcCtD
Losartan—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00012	0.000531	CcSEcCtD
Losartan—Weight increased—Epirubicin—peripheral nervous system neoplasm	0.00012	0.00053	CcSEcCtD
Losartan—Pancreatitis—Doxorubicin—peripheral nervous system neoplasm	0.00012	0.000529	CcSEcCtD
Losartan—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000119	0.000527	CcSEcCtD
Losartan—Hyperglycaemia—Epirubicin—peripheral nervous system neoplasm	0.000119	0.000526	CcSEcCtD
Losartan—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000119	0.000526	CcSEcCtD
Losartan—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000119	0.000525	CcSEcCtD
Losartan—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000119	0.000524	CcSEcCtD
Losartan—Pneumonia—Epirubicin—peripheral nervous system neoplasm	0.000118	0.000523	CcSEcCtD
Losartan—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000118	0.000519	CcSEcCtD
Losartan—Bronchitis—Doxorubicin—peripheral nervous system neoplasm	0.000118	0.000519	CcSEcCtD
Losartan—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000117	0.000518	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Epirubicin—peripheral nervous system neoplasm	0.000117	0.000515	CcSEcCtD
Losartan—Rash—Dactinomycin—peripheral nervous system neoplasm	0.000117	0.000515	CcSEcCtD
Losartan—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000117	0.000514	CcSEcCtD
Losartan—Renal failure—Epirubicin—peripheral nervous system neoplasm	0.000116	0.000511	CcSEcCtD
Losartan—Body temperature increased—Cisplatin—peripheral nervous system neoplasm	0.000116	0.00051	CcSEcCtD
Losartan—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000116	0.00051	CcSEcCtD
Losartan—Neuropathy peripheral—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000509	CcSEcCtD
Losartan—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000507	CcSEcCtD
Losartan—Constipation—Etoposide—peripheral nervous system neoplasm	0.000115	0.000506	CcSEcCtD
Losartan—Pain—Etoposide—peripheral nervous system neoplasm	0.000115	0.000506	CcSEcCtD
Losartan—Urinary tract infection—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000505	CcSEcCtD
Losartan—Conjunctivitis—Epirubicin—peripheral nervous system neoplasm	0.000115	0.000505	CcSEcCtD
Losartan—Upper respiratory tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000114	0.000501	CcSEcCtD
Losartan—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000114	0.000501	CcSEcCtD
Losartan—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.000113	0.000499	CcSEcCtD
Losartan—Sweating—Epirubicin—peripheral nervous system neoplasm	0.000113	0.000498	CcSEcCtD
Losartan—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000113	0.000498	CcSEcCtD
Losartan—Photosensitivity reaction—Doxorubicin—peripheral nervous system neoplasm	0.000112	0.000492	CcSEcCtD
Losartan—Weight increased—Doxorubicin—peripheral nervous system neoplasm	0.000111	0.000491	CcSEcCtD
Losartan—Epistaxis—Epirubicin—peripheral nervous system neoplasm	0.000111	0.00049	CcSEcCtD
Losartan—Sinusitis—Epirubicin—peripheral nervous system neoplasm	0.000111	0.000488	CcSEcCtD
Losartan—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.00011	0.000487	CcSEcCtD
Losartan—Hyperglycaemia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000486	CcSEcCtD
Losartan—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.00011	0.000485	CcSEcCtD
Losartan—Agranulocytosis—Epirubicin—peripheral nervous system neoplasm	0.00011	0.000485	CcSEcCtD
Losartan—Pneumonia—Doxorubicin—peripheral nervous system neoplasm	0.00011	0.000484	CcSEcCtD
Losartan—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00011	0.000483	CcSEcCtD
Losartan—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000109	0.000483	CcSEcCtD
Losartan—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000109	0.000482	CcSEcCtD
Losartan—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000478	CcSEcCtD
Losartan—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000477	CcSEcCtD
Losartan—Stevens-Johnson syndrome—Doxorubicin—peripheral nervous system neoplasm	0.000108	0.000477	CcSEcCtD
Losartan—Hypersensitivity—Cisplatin—peripheral nervous system neoplasm	0.000108	0.000475	CcSEcCtD
Losartan—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000108	0.000475	CcSEcCtD
Losartan—Renal failure—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000473	CcSEcCtD
Losartan—Neuropathy peripheral—Doxorubicin—peripheral nervous system neoplasm	0.000107	0.000471	CcSEcCtD
Losartan—Urticaria—Etoposide—peripheral nervous system neoplasm	0.000106	0.00047	CcSEcCtD
Losartan—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000469	CcSEcCtD
Losartan—Rhinitis—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000468	CcSEcCtD
Losartan—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.000106	0.000467	CcSEcCtD
Losartan—Body temperature increased—Etoposide—peripheral nervous system neoplasm	0.000106	0.000467	CcSEcCtD
Losartan—Conjunctivitis—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000467	CcSEcCtD
Losartan—Urinary tract infection—Doxorubicin—peripheral nervous system neoplasm	0.000106	0.000467	CcSEcCtD
Losartan—Hepatitis—Epirubicin—peripheral nervous system neoplasm	0.000106	0.000466	CcSEcCtD
Losartan—Hypoaesthesia—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000464	CcSEcCtD
Losartan—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000105	0.000464	CcSEcCtD
Losartan—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000105	0.000463	CcSEcCtD
Losartan—Pharyngitis—Epirubicin—peripheral nervous system neoplasm	0.000105	0.000463	CcSEcCtD
Losartan—Sweating—Doxorubicin—peripheral nervous system neoplasm	0.000104	0.000461	CcSEcCtD
Losartan—Rash—Vincristine—peripheral nervous system neoplasm	0.000104	0.00046	CcSEcCtD
Losartan—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.000104	0.00046	CcSEcCtD
Losartan—Headache—Vincristine—peripheral nervous system neoplasm	0.000104	0.000457	CcSEcCtD
Losartan—Epistaxis—Doxorubicin—peripheral nervous system neoplasm	0.000103	0.000454	CcSEcCtD
Losartan—Sinusitis—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000451	CcSEcCtD
Losartan—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000102	0.00045	CcSEcCtD
Losartan—Agranulocytosis—Doxorubicin—peripheral nervous system neoplasm	0.000102	0.000449	CcSEcCtD
Losartan—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.0001	0.000442	CcSEcCtD
Losartan—Erythema multiforme—Epirubicin—peripheral nervous system neoplasm	0.0001	0.000441	CcSEcCtD
Losartan—Hypersensitivity—Etoposide—peripheral nervous system neoplasm	9.87e-05	0.000436	CcSEcCtD
Losartan—Tinnitus—Epirubicin—peripheral nervous system neoplasm	9.86e-05	0.000435	CcSEcCtD
Losartan—Nausea—Vincristine—peripheral nervous system neoplasm	9.83e-05	0.000434	CcSEcCtD
Losartan—Flushing—Epirubicin—peripheral nervous system neoplasm	9.81e-05	0.000433	CcSEcCtD
Losartan—Rhinitis—Doxorubicin—peripheral nervous system neoplasm	9.81e-05	0.000433	CcSEcCtD
Losartan—Hepatitis—Doxorubicin—peripheral nervous system neoplasm	9.78e-05	0.000432	CcSEcCtD
Losartan—Hypoaesthesia—Doxorubicin—peripheral nervous system neoplasm	9.74e-05	0.000429	CcSEcCtD
Losartan—Pharyngitis—Doxorubicin—peripheral nervous system neoplasm	9.71e-05	0.000428	CcSEcCtD
Losartan—Asthenia—Etoposide—peripheral nervous system neoplasm	9.62e-05	0.000424	CcSEcCtD
Losartan—Angiopathy—Epirubicin—peripheral nervous system neoplasm	9.59e-05	0.000423	CcSEcCtD
Losartan—Pruritus—Etoposide—peripheral nervous system neoplasm	9.48e-05	0.000418	CcSEcCtD
Losartan—Arrhythmia—Epirubicin—peripheral nervous system neoplasm	9.45e-05	0.000417	CcSEcCtD
Losartan—Alopecia—Epirubicin—peripheral nervous system neoplasm	9.34e-05	0.000412	CcSEcCtD
Losartan—Vomiting—Cisplatin—peripheral nervous system neoplasm	9.3e-05	0.00041	CcSEcCtD
Losartan—Erythema multiforme—Doxorubicin—peripheral nervous system neoplasm	9.25e-05	0.000408	CcSEcCtD
Losartan—Rash—Cisplatin—peripheral nervous system neoplasm	9.22e-05	0.000407	CcSEcCtD
Losartan—Dermatitis—Cisplatin—peripheral nervous system neoplasm	9.22e-05	0.000407	CcSEcCtD
Losartan—Erythema—Epirubicin—peripheral nervous system neoplasm	9.21e-05	0.000406	CcSEcCtD
Losartan—Diarrhoea—Etoposide—peripheral nervous system neoplasm	9.17e-05	0.000405	CcSEcCtD
Losartan—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	9.12e-05	0.000402	CcSEcCtD
Losartan—Flushing—Doxorubicin—peripheral nervous system neoplasm	9.08e-05	0.000401	CcSEcCtD
Losartan—Flatulence—Epirubicin—peripheral nervous system neoplasm	9.07e-05	0.0004	CcSEcCtD
Losartan—Tension—Epirubicin—peripheral nervous system neoplasm	9.03e-05	0.000398	CcSEcCtD
Losartan—Dysgeusia—Epirubicin—peripheral nervous system neoplasm	9.01e-05	0.000398	CcSEcCtD
Losartan—Nervousness—Epirubicin—peripheral nervous system neoplasm	8.94e-05	0.000394	CcSEcCtD
Losartan—Back pain—Epirubicin—peripheral nervous system neoplasm	8.9e-05	0.000393	CcSEcCtD
Losartan—Angiopathy—Doxorubicin—peripheral nervous system neoplasm	8.88e-05	0.000392	CcSEcCtD
Losartan—Dizziness—Etoposide—peripheral nervous system neoplasm	8.86e-05	0.000391	CcSEcCtD
Losartan—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	8.85e-05	0.00039	CcSEcCtD
Losartan—Arrhythmia—Doxorubicin—peripheral nervous system neoplasm	8.74e-05	0.000386	CcSEcCtD
Losartan—Nausea—Cisplatin—peripheral nervous system neoplasm	8.69e-05	0.000383	CcSEcCtD
Losartan—Vision blurred—Epirubicin—peripheral nervous system neoplasm	8.68e-05	0.000383	CcSEcCtD
Losartan—Alopecia—Doxorubicin—peripheral nervous system neoplasm	8.65e-05	0.000381	CcSEcCtD
Losartan—Ill-defined disorder—Epirubicin—peripheral nervous system neoplasm	8.54e-05	0.000377	CcSEcCtD
Losartan—Vomiting—Etoposide—peripheral nervous system neoplasm	8.52e-05	0.000376	CcSEcCtD
Losartan—Erythema—Doxorubicin—peripheral nervous system neoplasm	8.52e-05	0.000376	CcSEcCtD
Losartan—Anaemia—Epirubicin—peripheral nervous system neoplasm	8.51e-05	0.000375	CcSEcCtD
Losartan—Agitation—Epirubicin—peripheral nervous system neoplasm	8.46e-05	0.000373	CcSEcCtD
Losartan—Rash—Etoposide—peripheral nervous system neoplasm	8.45e-05	0.000373	CcSEcCtD
Losartan—Dermatitis—Etoposide—peripheral nervous system neoplasm	8.44e-05	0.000372	CcSEcCtD
Losartan—Headache—Etoposide—peripheral nervous system neoplasm	8.4e-05	0.00037	CcSEcCtD
Losartan—Flatulence—Doxorubicin—peripheral nervous system neoplasm	8.39e-05	0.00037	CcSEcCtD
Losartan—Tension—Doxorubicin—peripheral nervous system neoplasm	8.36e-05	0.000369	CcSEcCtD
Losartan—Dysgeusia—Doxorubicin—peripheral nervous system neoplasm	8.34e-05	0.000368	CcSEcCtD
Losartan—Malaise—Epirubicin—peripheral nervous system neoplasm	8.3e-05	0.000366	CcSEcCtD
Losartan—Nervousness—Doxorubicin—peripheral nervous system neoplasm	8.27e-05	0.000365	CcSEcCtD
Losartan—Vertigo—Epirubicin—peripheral nervous system neoplasm	8.27e-05	0.000365	CcSEcCtD
Losartan—Syncope—Epirubicin—peripheral nervous system neoplasm	8.26e-05	0.000364	CcSEcCtD
Losartan—Leukopenia—Epirubicin—peripheral nervous system neoplasm	8.24e-05	0.000363	CcSEcCtD
Losartan—Back pain—Doxorubicin—peripheral nervous system neoplasm	8.24e-05	0.000363	CcSEcCtD
Losartan—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	8.19e-05	0.000361	CcSEcCtD
Losartan—Palpitations—Epirubicin—peripheral nervous system neoplasm	8.13e-05	0.000359	CcSEcCtD
Losartan—Loss of consciousness—Epirubicin—peripheral nervous system neoplasm	8.09e-05	0.000357	CcSEcCtD
Losartan—Cough—Epirubicin—peripheral nervous system neoplasm	8.03e-05	0.000354	CcSEcCtD
Losartan—Vision blurred—Doxorubicin—peripheral nervous system neoplasm	8.03e-05	0.000354	CcSEcCtD
Losartan—Nausea—Etoposide—peripheral nervous system neoplasm	7.96e-05	0.000351	CcSEcCtD
Losartan—Ill-defined disorder—Doxorubicin—peripheral nervous system neoplasm	7.9e-05	0.000349	CcSEcCtD
Losartan—Anaemia—Doxorubicin—peripheral nervous system neoplasm	7.87e-05	0.000347	CcSEcCtD
Losartan—Chest pain—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.000346	CcSEcCtD
Losartan—Arthralgia—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.000346	CcSEcCtD
Losartan—Myalgia—Epirubicin—peripheral nervous system neoplasm	7.84e-05	0.000346	CcSEcCtD
Losartan—Agitation—Doxorubicin—peripheral nervous system neoplasm	7.83e-05	0.000345	CcSEcCtD
Losartan—Anxiety—Epirubicin—peripheral nervous system neoplasm	7.81e-05	0.000345	CcSEcCtD
Losartan—Discomfort—Epirubicin—peripheral nervous system neoplasm	7.74e-05	0.000342	CcSEcCtD
Losartan—Malaise—Doxorubicin—peripheral nervous system neoplasm	7.68e-05	0.000339	CcSEcCtD
Losartan—Dry mouth—Epirubicin—peripheral nervous system neoplasm	7.66e-05	0.000338	CcSEcCtD
Losartan—Vertigo—Doxorubicin—peripheral nervous system neoplasm	7.65e-05	0.000338	CcSEcCtD
Losartan—Syncope—Doxorubicin—peripheral nervous system neoplasm	7.64e-05	0.000337	CcSEcCtD
Losartan—Leukopenia—Doxorubicin—peripheral nervous system neoplasm	7.62e-05	0.000336	CcSEcCtD
Losartan—Confusional state—Epirubicin—peripheral nervous system neoplasm	7.58e-05	0.000334	CcSEcCtD
Losartan—Palpitations—Doxorubicin—peripheral nervous system neoplasm	7.53e-05	0.000332	CcSEcCtD
Losartan—Oedema—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.000331	CcSEcCtD
Losartan—Anaphylactic shock—Epirubicin—peripheral nervous system neoplasm	7.51e-05	0.000331	CcSEcCtD
Losartan—Loss of consciousness—Doxorubicin—peripheral nervous system neoplasm	7.49e-05	0.00033	CcSEcCtD
Losartan—Infection—Epirubicin—peripheral nervous system neoplasm	7.46e-05	0.000329	CcSEcCtD
Losartan—Cough—Doxorubicin—peripheral nervous system neoplasm	7.43e-05	0.000328	CcSEcCtD
Losartan—Shock—Epirubicin—peripheral nervous system neoplasm	7.39e-05	0.000326	CcSEcCtD
Losartan—Nervous system disorder—Epirubicin—peripheral nervous system neoplasm	7.37e-05	0.000325	CcSEcCtD
Losartan—Thrombocytopenia—Epirubicin—peripheral nervous system neoplasm	7.36e-05	0.000324	CcSEcCtD
Losartan—Tachycardia—Epirubicin—peripheral nervous system neoplasm	7.33e-05	0.000323	CcSEcCtD
Losartan—Hyperhidrosis—Epirubicin—peripheral nervous system neoplasm	7.26e-05	0.00032	CcSEcCtD
Losartan—Chest pain—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.00032	CcSEcCtD
Losartan—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.00032	CcSEcCtD
Losartan—Myalgia—Doxorubicin—peripheral nervous system neoplasm	7.25e-05	0.00032	CcSEcCtD
Losartan—Anxiety—Doxorubicin—peripheral nervous system neoplasm	7.23e-05	0.000319	CcSEcCtD
Losartan—Discomfort—Doxorubicin—peripheral nervous system neoplasm	7.16e-05	0.000316	CcSEcCtD
Losartan—Anorexia—Epirubicin—peripheral nervous system neoplasm	7.16e-05	0.000316	CcSEcCtD
Losartan—Dry mouth—Doxorubicin—peripheral nervous system neoplasm	7.09e-05	0.000313	CcSEcCtD
Losartan—Hypotension—Epirubicin—peripheral nervous system neoplasm	7.02e-05	0.00031	CcSEcCtD
Losartan—Confusional state—Doxorubicin—peripheral nervous system neoplasm	7.01e-05	0.000309	CcSEcCtD
Losartan—Anaphylactic shock—Doxorubicin—peripheral nervous system neoplasm	6.95e-05	0.000307	CcSEcCtD
Losartan—Oedema—Doxorubicin—peripheral nervous system neoplasm	6.95e-05	0.000307	CcSEcCtD
Losartan—Infection—Doxorubicin—peripheral nervous system neoplasm	6.91e-05	0.000305	CcSEcCtD
Losartan—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	6.84e-05	0.000302	CcSEcCtD
Losartan—Shock—Doxorubicin—peripheral nervous system neoplasm	6.84e-05	0.000302	CcSEcCtD
Losartan—Nervous system disorder—Doxorubicin—peripheral nervous system neoplasm	6.82e-05	0.000301	CcSEcCtD
Losartan—Thrombocytopenia—Doxorubicin—peripheral nervous system neoplasm	6.81e-05	0.0003	CcSEcCtD
Losartan—Insomnia—Epirubicin—peripheral nervous system neoplasm	6.8e-05	0.0003	CcSEcCtD
Losartan—Tachycardia—Doxorubicin—peripheral nervous system neoplasm	6.78e-05	0.000299	CcSEcCtD
Losartan—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	6.75e-05	0.000298	CcSEcCtD
Losartan—Hyperhidrosis—Doxorubicin—peripheral nervous system neoplasm	6.72e-05	0.000296	CcSEcCtD
Losartan—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	6.7e-05	0.000295	CcSEcCtD
Losartan—Somnolence—Epirubicin—peripheral nervous system neoplasm	6.68e-05	0.000295	CcSEcCtD
Losartan—Anorexia—Doxorubicin—peripheral nervous system neoplasm	6.63e-05	0.000292	CcSEcCtD
Losartan—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	6.61e-05	0.000292	CcSEcCtD
Losartan—AGTR1—Signaling by GPCR—CD55—peripheral nervous system neoplasm	6.57e-05	0.00245	CbGpPWpGaD
Losartan—ALB—Platelet degranulation—HGF—peripheral nervous system neoplasm	6.55e-05	0.00244	CbGpPWpGaD
Losartan—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	6.53e-05	0.000288	CcSEcCtD
Losartan—Hypotension—Doxorubicin—peripheral nervous system neoplasm	6.5e-05	0.000287	CcSEcCtD
Losartan—Fatigue—Epirubicin—peripheral nervous system neoplasm	6.48e-05	0.000286	CcSEcCtD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—PTPN11—peripheral nervous system neoplasm	6.47e-05	0.00241	CbGpPWpGaD
Losartan—Constipation—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000283	CcSEcCtD
Losartan—Pain—Epirubicin—peripheral nervous system neoplasm	6.42e-05	0.000283	CcSEcCtD
Losartan—SLC22A6—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	6.41e-05	0.00238	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	6.35e-05	0.00236	CbGpPWpGaD
Losartan—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	6.33e-05	0.000279	CcSEcCtD
Losartan—Insomnia—Doxorubicin—peripheral nervous system neoplasm	6.29e-05	0.000277	CcSEcCtD
Losartan—ALB—Response to elevated platelet cytosolic Ca2+—HGF—peripheral nervous system neoplasm	6.24e-05	0.00232	CbGpPWpGaD
Losartan—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	6.24e-05	0.000275	CcSEcCtD
Losartan—UGT1A3—Metabolism—HSD17B12—peripheral nervous system neoplasm	6.2e-05	0.00231	CbGpPWpGaD
Losartan—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	6.2e-05	0.000273	CcSEcCtD
Losartan—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	6.19e-05	0.000273	CcSEcCtD
Losartan—Somnolence—Doxorubicin—peripheral nervous system neoplasm	6.18e-05	0.000273	CcSEcCtD
Losartan—SLC22A6—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	6.15e-05	0.00229	CbGpPWpGaD
Losartan—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	6.14e-05	0.000271	CcSEcCtD
Losartan—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	6.12e-05	0.00027	CcSEcCtD
Losartan—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	6.04e-05	0.000267	CcSEcCtD
Losartan—AGTR1—GPCR ligand binding—KNG1—peripheral nervous system neoplasm	6e-05	0.00224	CbGpPWpGaD
Losartan—Fatigue—Doxorubicin—peripheral nervous system neoplasm	5.99e-05	0.000264	CcSEcCtD
Losartan—Urticaria—Epirubicin—peripheral nervous system neoplasm	5.97e-05	0.000263	CcSEcCtD
Losartan—Pain—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000262	CcSEcCtD
Losartan—Constipation—Doxorubicin—peripheral nervous system neoplasm	5.94e-05	0.000262	CcSEcCtD
Losartan—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000262	CcSEcCtD
Losartan—Body temperature increased—Epirubicin—peripheral nervous system neoplasm	5.94e-05	0.000262	CcSEcCtD
Losartan—SLCO1B3—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.85e-05	0.00218	CbGpPWpGaD
Losartan—SLCO1B1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	5.83e-05	0.00217	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	5.82e-05	0.00216	CbGpPWpGaD
Losartan—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	5.73e-05	0.000253	CcSEcCtD
Losartan—AGTR1—GPCR downstream signaling—VIP—peripheral nervous system neoplasm	5.72e-05	0.00213	CbGpPWpGaD
Losartan—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	5.68e-05	0.000251	CcSEcCtD
Losartan—SLCO1B1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	5.6e-05	0.00208	CbGpPWpGaD
Losartan—Hypersensitivity—Epirubicin—peripheral nervous system neoplasm	5.54e-05	0.000244	CcSEcCtD
Losartan—Urticaria—Doxorubicin—peripheral nervous system neoplasm	5.52e-05	0.000244	CcSEcCtD
Losartan—Body temperature increased—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000242	CcSEcCtD
Losartan—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	5.5e-05	0.000242	CcSEcCtD
Losartan—Asthenia—Epirubicin—peripheral nervous system neoplasm	5.39e-05	0.000238	CcSEcCtD
Losartan—Pruritus—Epirubicin—peripheral nervous system neoplasm	5.32e-05	0.000234	CcSEcCtD
Losartan—UGT2B7—Metabolism—HSD17B12—peripheral nervous system neoplasm	5.28e-05	0.00196	CbGpPWpGaD
Losartan—AGTR1—GPCR ligand binding—GNAS—peripheral nervous system neoplasm	5.25e-05	0.00195	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—VIP—peripheral nervous system neoplasm	5.2e-05	0.00193	CbGpPWpGaD
Losartan—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	5.14e-05	0.000227	CcSEcCtD
Losartan—Hypersensitivity—Doxorubicin—peripheral nervous system neoplasm	5.12e-05	0.000226	CcSEcCtD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.07e-05	0.00189	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	5.04e-05	0.00188	CbGpPWpGaD
Losartan—Asthenia—Doxorubicin—peripheral nervous system neoplasm	4.99e-05	0.00022	CcSEcCtD
Losartan—Dizziness—Epirubicin—peripheral nervous system neoplasm	4.97e-05	0.000219	CcSEcCtD
Losartan—Pruritus—Doxorubicin—peripheral nervous system neoplasm	4.92e-05	0.000217	CcSEcCtD
Losartan—SLCO1B3—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	4.86e-05	0.00181	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PPP3R1—peripheral nervous system neoplasm	4.8e-05	0.00179	CbGpPWpGaD
Losartan—Vomiting—Epirubicin—peripheral nervous system neoplasm	4.78e-05	0.000211	CcSEcCtD
Losartan—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	4.76e-05	0.00021	CcSEcCtD
Losartan—Rash—Epirubicin—peripheral nervous system neoplasm	4.74e-05	0.000209	CcSEcCtD
Losartan—Dermatitis—Epirubicin—peripheral nervous system neoplasm	4.73e-05	0.000209	CcSEcCtD
Losartan—Headache—Epirubicin—peripheral nervous system neoplasm	4.71e-05	0.000208	CcSEcCtD
Losartan—Dizziness—Doxorubicin—peripheral nervous system neoplasm	4.6e-05	0.000203	CcSEcCtD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.52e-05	0.00168	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GNS—peripheral nervous system neoplasm	4.49e-05	0.00167	CbGpPWpGaD
Losartan—Nausea—Epirubicin—peripheral nervous system neoplasm	4.46e-05	0.000197	CcSEcCtD
Losartan—Vomiting—Doxorubicin—peripheral nervous system neoplasm	4.42e-05	0.000195	CcSEcCtD
Losartan—SLCO1B3—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	4.41e-05	0.00164	CbGpPWpGaD
Losartan—Rash—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000193	CcSEcCtD
Losartan—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	4.38e-05	0.000193	CcSEcCtD
Losartan—Headache—Doxorubicin—peripheral nervous system neoplasm	4.35e-05	0.000192	CcSEcCtD
Losartan—UGT1A3—Metabolism—NME1—peripheral nervous system neoplasm	4.3e-05	0.0016	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	4.29e-05	0.0016	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GNS—peripheral nervous system neoplasm	4.23e-05	0.00157	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—COX2—peripheral nervous system neoplasm	4.14e-05	0.00154	CbGpPWpGaD
Losartan—Nausea—Doxorubicin—peripheral nervous system neoplasm	4.13e-05	0.000182	CcSEcCtD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	4.13e-05	0.00154	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—NME1—peripheral nervous system neoplasm	4.05e-05	0.00151	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NTS—peripheral nervous system neoplasm	4.05e-05	0.00151	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—HSD17B12—peripheral nervous system neoplasm	3.93e-05	0.00146	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—COX2—peripheral nervous system neoplasm	3.9e-05	0.00145	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—NRAS—peripheral nervous system neoplasm	3.89e-05	0.00145	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CD55—peripheral nervous system neoplasm	3.88e-05	0.00145	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.86e-05	0.00144	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GNS—peripheral nervous system neoplasm	3.81e-05	0.00142	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—NME1—peripheral nervous system neoplasm	3.66e-05	0.00136	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—peripheral nervous system neoplasm	3.59e-05	0.00134	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	3.55e-05	0.00132	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—HSD17B12—peripheral nervous system neoplasm	3.53e-05	0.00131	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—COX2—peripheral nervous system neoplasm	3.52e-05	0.00131	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—KNG1—peripheral nervous system neoplasm	3.49e-05	0.0013	CbGpPWpGaD
Losartan—SLCO1B3—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	3.48e-05	0.0013	CbGpPWpGaD
Losartan—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—peripheral nervous system neoplasm	3.47e-05	0.00129	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—KNG1—peripheral nervous system neoplasm	3.39e-05	0.00126	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.34e-05	0.00124	CbGpPWpGaD
Losartan—ALB—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	3.33e-05	0.00124	CbGpPWpGaD
Losartan—ALB—Metabolism—PPIP5K2—peripheral nervous system neoplasm	3.32e-05	0.00124	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—NTRK1—peripheral nervous system neoplasm	3.27e-05	0.00122	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	3.26e-05	0.00122	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	3.26e-05	0.00121	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	3.2e-05	0.00119	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—NRAS—peripheral nervous system neoplasm	3.13e-05	0.00117	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GNS—peripheral nervous system neoplasm	3.1e-05	0.00115	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—KNG1—peripheral nervous system neoplasm	3.08e-05	0.00115	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—VIP—peripheral nervous system neoplasm	3.07e-05	0.00114	CbGpPWpGaD
Losartan—ABCB1—Allograft Rejection—CASP3—peripheral nervous system neoplasm	3.03e-05	0.00113	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—peripheral nervous system neoplasm	3e-05	0.00112	CbGpPWpGaD
Losartan—ALB—FOXA2 and FOXA3 transcription factor networks—AKT1—peripheral nervous system neoplasm	3e-05	0.00111	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.98e-05	0.00111	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—NME1—peripheral nervous system neoplasm	2.97e-05	0.00111	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—GNAS—peripheral nervous system neoplasm	2.97e-05	0.0011	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	2.96e-05	0.0011	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—MYC—peripheral nervous system neoplasm	2.92e-05	0.00109	CbGpPWpGaD
Losartan—ABCB1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.91e-05	0.00108	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—HGF—peripheral nervous system neoplasm	2.91e-05	0.00108	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—COX2—peripheral nervous system neoplasm	2.86e-05	0.00106	CbGpPWpGaD
Losartan—AGTR1—Gastrin-CREB signalling pathway via PKC and MAPK—HRAS—peripheral nervous system neoplasm	2.85e-05	0.00106	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GNS—peripheral nervous system neoplasm	2.84e-05	0.00106	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PPP3R1—peripheral nervous system neoplasm	2.83e-05	0.00105	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	2.8e-05	0.00104	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—NME1—peripheral nervous system neoplasm	2.72e-05	0.00101	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.72e-05	0.00101	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ENO2—peripheral nervous system neoplasm	2.72e-05	0.00101	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—GNAS—peripheral nervous system neoplasm	2.69e-05	0.001	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—COX2—peripheral nervous system neoplasm	2.62e-05	0.000976	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.62e-05	0.000975	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.61e-05	0.00097	CbGpPWpGaD
Losartan—SLC22A6—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.57e-05	0.000957	CbGpPWpGaD
Losartan—ALB—Folate Metabolism—TP53—peripheral nervous system neoplasm	2.56e-05	0.000955	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ENO2—peripheral nervous system neoplasm	2.56e-05	0.000953	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	2.38e-05	0.000887	CbGpPWpGaD
Losartan—SLCO1B1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	2.34e-05	0.00087	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	2.32e-05	0.000865	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ENO2—peripheral nervous system neoplasm	2.31e-05	0.00086	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—BCHE—peripheral nervous system neoplasm	2.3e-05	0.000855	CbGpPWpGaD
Losartan—CYP1A2—Aryl Hydrocarbon Receptor—HRAS—peripheral nervous system neoplasm	2.29e-05	0.000852	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.26e-05	0.00084	CbGpPWpGaD
Losartan—ALB—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.24e-05	0.000836	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.19e-05	0.000815	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—BCHE—peripheral nervous system neoplasm	2.16e-05	0.000806	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—TH—peripheral nervous system neoplasm	2.16e-05	0.000804	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NTRK2—peripheral nervous system neoplasm	2.13e-05	0.000792	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—SLC2A1—peripheral nervous system neoplasm	2.06e-05	0.000768	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—TH—peripheral nervous system neoplasm	2.03e-05	0.000757	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—HSD17B12—peripheral nervous system neoplasm	2.01e-05	0.00075	CbGpPWpGaD
Losartan—ABCB1—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.97e-05	0.000732	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—BCHE—peripheral nervous system neoplasm	1.95e-05	0.000727	CbGpPWpGaD
Losartan—ALB—Hemostasis—IFNB1—peripheral nervous system neoplasm	1.94e-05	0.000722	CbGpPWpGaD
Losartan—UGT2B17—Metabolism—AKT1—peripheral nervous system neoplasm	1.93e-05	0.00072	CbGpPWpGaD
Losartan—ABCB1—HIF-1-alpha transcription factor network—AKT1—peripheral nervous system neoplasm	1.9e-05	0.000706	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GNS—peripheral nervous system neoplasm	1.88e-05	0.000701	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ENO2—peripheral nervous system neoplasm	1.88e-05	0.000699	CbGpPWpGaD
Losartan—CYP2C8—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.88e-05	0.000698	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—PTPN11—peripheral nervous system neoplasm	1.87e-05	0.000697	CbGpPWpGaD
Losartan—ALB—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.87e-05	0.000694	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.86e-05	0.000693	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.84e-05	0.000684	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—TH—peripheral nervous system neoplasm	1.84e-05	0.000683	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—KNG1—peripheral nervous system neoplasm	1.82e-05	0.000678	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—NME1—peripheral nervous system neoplasm	1.81e-05	0.000672	CbGpPWpGaD
Losartan—ALB—Hemostasis—KNG1—peripheral nervous system neoplasm	1.8e-05	0.000669	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—PPIP5K2—peripheral nervous system neoplasm	1.79e-05	0.000668	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—GNAS—peripheral nervous system neoplasm	1.76e-05	0.000656	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—COX2—peripheral nervous system neoplasm	1.74e-05	0.000647	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NTRK1—peripheral nervous system neoplasm	1.73e-05	0.000646	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.73e-05	0.000644	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ENO2—peripheral nervous system neoplasm	1.72e-05	0.000641	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.69e-05	0.00063	CbGpPWpGaD
Losartan—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.67e-05	0.000623	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—GNAS—peripheral nervous system neoplasm	1.66e-05	0.000618	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—peripheral nervous system neoplasm	1.65e-05	0.000614	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GNS—peripheral nervous system neoplasm	1.63e-05	0.000608	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—ABCB1—peripheral nervous system neoplasm	1.63e-05	0.000607	CbGpPWpGaD
Losartan—ALB—Metabolism—GNS—peripheral nervous system neoplasm	1.62e-05	0.000604	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—GNAS—peripheral nervous system neoplasm	1.59e-05	0.000593	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—BCHE—peripheral nervous system neoplasm	1.59e-05	0.000591	CbGpPWpGaD
Losartan—ALB—Hemostasis—GNAS—peripheral nervous system neoplasm	1.57e-05	0.000585	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.57e-05	0.000584	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—NME1—peripheral nervous system neoplasm	1.56e-05	0.000582	CbGpPWpGaD
Losartan—ALB—Metabolism—NME1—peripheral nervous system neoplasm	1.56e-05	0.000579	CbGpPWpGaD
Losartan—CYP2C9—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.53e-05	0.000568	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.51e-05	0.000563	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—COX2—peripheral nervous system neoplasm	1.51e-05	0.000561	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—GNAS—peripheral nervous system neoplasm	1.5e-05	0.000558	CbGpPWpGaD
Losartan—ALB—Hemostasis—HGF—peripheral nervous system neoplasm	1.5e-05	0.000558	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—CASP3—peripheral nervous system neoplasm	1.5e-05	0.000557	CbGpPWpGaD
Losartan—ALB—Metabolism—COX2—peripheral nervous system neoplasm	1.5e-05	0.000557	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—TH—peripheral nervous system neoplasm	1.49e-05	0.000555	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	1.48e-05	0.000552	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—ABCB1—peripheral nervous system neoplasm	1.47e-05	0.000547	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GNS—peripheral nervous system neoplasm	1.46e-05	0.000542	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—BCHE—peripheral nervous system neoplasm	1.45e-05	0.000541	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GNS—peripheral nervous system neoplasm	1.42e-05	0.000529	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—NME1—peripheral nervous system neoplasm	1.4e-05	0.00052	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—SLC2A1—peripheral nervous system neoplasm	1.39e-05	0.000516	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—TH—peripheral nervous system neoplasm	1.37e-05	0.000509	CbGpPWpGaD
Losartan—ABCB1—Metabolism—NME1—peripheral nervous system neoplasm	1.36e-05	0.000507	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.36e-05	0.000507	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—COX2—peripheral nervous system neoplasm	1.34e-05	0.0005	CbGpPWpGaD
Losartan—ALB—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	1.34e-05	0.000497	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GNS—peripheral nervous system neoplasm	1.33e-05	0.000494	CbGpPWpGaD
Losartan—ABCB1—Metabolism—COX2—peripheral nervous system neoplasm	1.31e-05	0.000488	CbGpPWpGaD
Losartan—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—peripheral nervous system neoplasm	1.3e-05	0.000486	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—NME1—peripheral nervous system neoplasm	1.27e-05	0.000474	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—COX2—peripheral nervous system neoplasm	1.23e-05	0.000456	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—GNAS—peripheral nervous system neoplasm	1.22e-05	0.000453	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—HSD17B12—peripheral nervous system neoplasm	1.21e-05	0.000451	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.2e-05	0.000445	CbGpPWpGaD
Losartan—ABCB1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	1.19e-05	0.000444	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—peripheral nervous system neoplasm	1.17e-05	0.000435	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ENO2—peripheral nervous system neoplasm	1.14e-05	0.000425	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GNS—peripheral nervous system neoplasm	1.14e-05	0.000423	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—NRAS—peripheral nervous system neoplasm	1.13e-05	0.000419	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—GNAS—peripheral nervous system neoplasm	1.12e-05	0.000415	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—PTPN11—peripheral nervous system neoplasm	1.11e-05	0.000412	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—ABCB1—peripheral nervous system neoplasm	1.1e-05	0.000408	CbGpPWpGaD
Losartan—ALB—Hemostasis—PTPN11—peripheral nervous system neoplasm	1.09e-05	0.000407	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—NME1—peripheral nervous system neoplasm	1.09e-05	0.000405	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—COX2—peripheral nervous system neoplasm	1.05e-05	0.00039	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ENO2—peripheral nervous system neoplasm	9.89e-06	0.000368	CbGpPWpGaD
Losartan—ALB—Metabolism—ENO2—peripheral nervous system neoplasm	9.83e-06	0.000366	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—BCHE—peripheral nervous system neoplasm	9.65e-06	0.000359	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—peripheral nervous system neoplasm	9.6e-06	0.000357	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—SLC2A1—peripheral nervous system neoplasm	9.2e-06	0.000343	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—TH—peripheral nervous system neoplasm	9.07e-06	0.000338	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ENO2—peripheral nervous system neoplasm	8.83e-06	0.000329	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GNS—peripheral nervous system neoplasm	8.76e-06	0.000326	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—ERBB2—peripheral nervous system neoplasm	8.74e-06	0.000325	CbGpPWpGaD
Losartan—ABCB1—Metabolism—ENO2—peripheral nervous system neoplasm	8.61e-06	0.000321	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—NME1—peripheral nervous system neoplasm	8.4e-06	0.000313	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—BCHE—peripheral nervous system neoplasm	8.36e-06	0.000311	CbGpPWpGaD
Losartan—ALB—Metabolism—BCHE—peripheral nervous system neoplasm	8.31e-06	0.000309	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—HRAS—peripheral nervous system neoplasm	8.24e-06	0.000307	CbGpPWpGaD
Losartan—ALB—Platelet activation, signaling and aggregation—AKT1—peripheral nervous system neoplasm	8.24e-06	0.000307	CbGpPWpGaD
Losartan—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—peripheral nervous system neoplasm	8.11e-06	0.000302	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—COX2—peripheral nervous system neoplasm	8.08e-06	0.000301	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ENO2—peripheral nervous system neoplasm	8.05e-06	0.0003	CbGpPWpGaD
Losartan—AGTR1—GPCR downstream signaling—AKT1—peripheral nervous system neoplasm	8.01e-06	0.000298	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.97e-06	0.000297	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—CASP3—peripheral nervous system neoplasm	7.94e-06	0.000295	CbGpPWpGaD
Losartan—ALB—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.93e-06	0.000295	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—TH—peripheral nervous system neoplasm	7.86e-06	0.000292	CbGpPWpGaD
Losartan—ALB—Metabolism—TH—peripheral nervous system neoplasm	7.81e-06	0.000291	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—BCHE—peripheral nervous system neoplasm	7.46e-06	0.000278	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—GNAS—peripheral nervous system neoplasm	7.4e-06	0.000276	CbGpPWpGaD
Losartan—ABCB1—Metabolism—BCHE—peripheral nervous system neoplasm	7.28e-06	0.000271	CbGpPWpGaD
Losartan—AGTR1—Signaling by GPCR—AKT1—peripheral nervous system neoplasm	7.27e-06	0.000271	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—ABCB1—peripheral nervous system neoplasm	7.27e-06	0.00027	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.11e-06	0.000265	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—TH—peripheral nervous system neoplasm	7.01e-06	0.000261	CbGpPWpGaD
Losartan—ABCB1—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.94e-06	0.000258	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ENO2—peripheral nervous system neoplasm	6.88e-06	0.000256	CbGpPWpGaD
Losartan—ABCB1—Metabolism—TH—peripheral nervous system neoplasm	6.84e-06	0.000255	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—BCHE—peripheral nervous system neoplasm	6.8e-06	0.000253	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—NRAS—peripheral nervous system neoplasm	6.65e-06	0.000248	CbGpPWpGaD
Losartan—ALB—Hemostasis—NRAS—peripheral nervous system neoplasm	6.57e-06	0.000245	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—SLC2A1—peripheral nervous system neoplasm	6.49e-06	0.000241	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—GNAS—peripheral nervous system neoplasm	6.41e-06	0.000239	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—TH—peripheral nervous system neoplasm	6.39e-06	0.000238	CbGpPWpGaD
Losartan—ALB—Metabolism—GNAS—peripheral nervous system neoplasm	6.38e-06	0.000237	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—ABCB1—peripheral nervous system neoplasm	6.29e-06	0.000234	CbGpPWpGaD
Losartan—ALB—Metabolism—ABCB1—peripheral nervous system neoplasm	6.26e-06	0.000233	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—MYC—peripheral nervous system neoplasm	6.2e-06	0.000231	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—BCHE—peripheral nervous system neoplasm	5.81e-06	0.000216	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—GNAS—peripheral nervous system neoplasm	5.72e-06	0.000213	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—ABCB1—peripheral nervous system neoplasm	5.62e-06	0.000209	CbGpPWpGaD
Losartan—ABCB1—Metabolism—GNAS—peripheral nervous system neoplasm	5.59e-06	0.000208	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	5.54e-06	0.000206	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—TH—peripheral nervous system neoplasm	5.46e-06	0.000203	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ENO2—peripheral nervous system neoplasm	5.31e-06	0.000198	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—GNAS—peripheral nervous system neoplasm	5.22e-06	0.000194	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—ABCB1—peripheral nervous system neoplasm	5.12e-06	0.000191	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—TP53—peripheral nervous system neoplasm	5.09e-06	0.000189	CbGpPWpGaD
Losartan—ALB—Hemostasis—TP53—peripheral nervous system neoplasm	5.03e-06	0.000187	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—HRAS—peripheral nervous system neoplasm	4.87e-06	0.000181	CbGpPWpGaD
Losartan—ALB—Hemostasis—HRAS—peripheral nervous system neoplasm	4.81e-06	0.000179	CbGpPWpGaD
Losartan—UGT1A3—Metabolism—AKT1—peripheral nervous system neoplasm	4.76e-06	0.000177	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—BCHE—peripheral nervous system neoplasm	4.48e-06	0.000167	CbGpPWpGaD
Losartan—SLCO1B3—Metabolism—AKT1—peripheral nervous system neoplasm	4.48e-06	0.000167	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—GNAS—peripheral nervous system neoplasm	4.46e-06	0.000166	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—ABCB1—peripheral nervous system neoplasm	4.38e-06	0.000163	CbGpPWpGaD
Losartan—AGTR1—Signaling Pathways—AKT1—peripheral nervous system neoplasm	4.3e-06	0.00016	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—SLC2A1—peripheral nervous system neoplasm	4.28e-06	0.000159	CbGpPWpGaD
Losartan—ALB—Hemostasis—AKT1—peripheral nervous system neoplasm	4.24e-06	0.000158	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—TH—peripheral nervous system neoplasm	4.22e-06	0.000157	CbGpPWpGaD
Losartan—UGT2B7—Metabolism—AKT1—peripheral nervous system neoplasm	4.05e-06	0.000151	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—GNAS—peripheral nervous system neoplasm	3.44e-06	0.000128	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—ABCB1—peripheral nervous system neoplasm	3.38e-06	0.000126	CbGpPWpGaD
Losartan—UGT1A1—Metabolism—AKT1—peripheral nervous system neoplasm	3.29e-06	0.000122	CbGpPWpGaD
Losartan—SLCO1B1—Metabolism—AKT1—peripheral nervous system neoplasm	3.01e-06	0.000112	CbGpPWpGaD
Losartan—CYP3A5—Metabolism—AKT1—peripheral nervous system neoplasm	2e-06	7.44e-05	CbGpPWpGaD
Losartan—CYP2C8—Metabolism—AKT1—peripheral nervous system neoplasm	1.73e-06	6.44e-05	CbGpPWpGaD
Losartan—ALB—Metabolism—AKT1—peripheral nervous system neoplasm	1.72e-06	6.41e-05	CbGpPWpGaD
Losartan—CYP2C19—Metabolism—AKT1—peripheral nervous system neoplasm	1.55e-06	5.75e-05	CbGpPWpGaD
Losartan—ABCB1—Metabolism—AKT1—peripheral nervous system neoplasm	1.51e-06	5.61e-05	CbGpPWpGaD
Losartan—CYP2C9—Metabolism—AKT1—peripheral nervous system neoplasm	1.41e-06	5.24e-05	CbGpPWpGaD
Losartan—CYP1A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.2e-06	4.48e-05	CbGpPWpGaD
Losartan—CYP3A4—Metabolism—AKT1—peripheral nervous system neoplasm	9.29e-07	3.46e-05	CbGpPWpGaD
